Eulalia Baselga Selected Research

Propranolol (Inderal)

6/2022	The VASCERN-VASCA working group diagnostic and management pathways for severe and/or rare infantile hemangiomas.
1/2021	Limited utility of repeated vital sign monitoring during initiation of oral propranolol for complicated infantile hemangioma.
1/2021	Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial.
7/2020	Propranolol-resistant infantile hemangioma successfully treated with sirolimus.
5/2020	Management of infantile hemangiomas during the COVID pandemic.
1/2020	Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE Syndrome.
1/2018	Interventions for infantile haemangiomas of the skin.
1/2018	Efficacy of Propranolol Between 6 and 12 Months of Age in High-Risk Infantile Hemangioma.
9/2016	Topical Timolol Maleate Treatment of Infantile Hemangiomas.
4/2016	Rebound Growth of Infantile Hemangiomas After Propranolol Therapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eulalia Baselga Research Topics

Disease

18	Hemangioma (Angioma) 06/2022 - 04/2008
4	Vascular Malformations 07/2020 - 01/2015
3	Atopic Dermatitis (Atopic Eczema) 05/2022 - 01/2020
3	Neoplasms (Cancer) 09/2020 - 07/2008
2	Necrosis 01/2021 - 01/2013
2	Stroke (Strokes) 01/2020 - 01/2013
2	Hypoglycemia (Reactive Hypoglycemia) 02/2015 - 01/2013
2	Eye Abnormalities (Eye Abnormality) 01/2013 - 01/2013
1	Premature Aging 01/2022
1	Condylomata Acuminata (Genital Wart) 09/2021
1	Port-Wine Stain (Nevus Flammeus) 03/2021
1	Central Nervous System Neoplasms 03/2021
1	Capillary Malformation-Arteriovenous Malformation 03/2020
1	Arteriovenous Malformations (Arteriovenous Malformation) 03/2020
1	Transient Ischemic Attack 01/2020
1	Ischemic Stroke 01/2020
1	Bullous Pemphigoid (Pemphigoid) 11/2019
1	Lethargy 01/2018
1	Injection Site Reaction 11/2017
1	Infections 11/2017
1	Obesity 11/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2017
1	Thinness 09/2016
1	Nevus (Nevi) 07/2016
1	Hypotension (Low Blood Pressure) 02/2015
1	Bronchial Spasm 02/2015
1	Bradycardia 02/2015
1	Body Weight (Weight, Body) 02/2015
1	Sturge-Weber Syndrome (Sturge-Kalischer-Weber Syndrome) 01/2015
1	Paresis (Hemiparesis) 01/2013
1	Aortic Coarctation 01/2013
1	Hypersensitivity (Allergy) 10/2008
1	Cutaneous Tuberculosis (Scrofuloderma) 10/2008
1	Vasculitis (Vasculitides) 10/2008
1	Hereditary Hemorrhagic Telangiectasia 07/2008
1	Pachyonychia Congenita (Jadassohn-Lewandowsky Syndrome) 12/2007
1	Lichen Sclerosus et Atrophicus (Lichen Sclerosus) 08/2006
1	Adams Oliver syndrome 05/2005
1	Seizures (Absence Seizure) 06/2004
1	Glaucoma 06/2004

Drug/Important Bio-Agent (IBA)

15	Propranolol (Inderal)FDA LinkGeneric 06/2022 - 03/2011
4	Sirolimus (Rapamycin)FDA Link 01/2021 - 01/2015
4	Pharmaceutical PreparationsIBA 07/2020 - 11/2017
3	Coloring Agents (Dyes)IBA 03/2021 - 06/2004
2	dupilumabIBA 05/2022 - 07/2021
2	Timolol (Blocadren)FDA LinkGeneric 01/2021 - 09/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2022
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2022
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2022
1	Papillomavirus Vaccines (HPV Vaccines)IBA 09/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 07/2021
1	Mitogen-Activated Protein KinasesIBA 03/2021
1	Rituximab (Mabthera)FDA Link 11/2019
1	Matrix Metalloproteinases (MMPs)IBA 11/2019
1	Dihydrotachysterol (AT 10)IBA 11/2018
1	Methotrexate (Mexate)FDA LinkGeneric 11/2017
1	Tumor Necrosis Factor InhibitorsIBA 11/2017
1	Transaminases (Aminotransferases)IBA 11/2017
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2017
1	CollagenIBA 07/2016
1	ElastinIBA 07/2016
1	SolutionsIBA 02/2015
1	Tuberculin (PPD)IBA 10/2008
1	TensinsIBA 07/2008
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2008
1	Glucose (Dextrose)FDA LinkGeneric 04/2008
1	Keratins (Keratin)IBA 12/2007
1	Ficusin (Psoralen)IBA 08/2006

Therapy/Procedure

10	Therapeutics 01/2021 - 01/2013
3	Dye Lasers 03/2020 - 01/2015
2	Duration of Therapy 01/2018 - 09/2016
1	Catheters 01/2021
1	Phototherapy (Light Therapy) 11/2017
1	Off-Label Use 09/2016
1	Injections 03/2014
1	Contraindications 01/2013
1	Sutures (Suture) 05/2005